Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Dermatology Physician in Los Angeles, CA
NPI: 1124026554Primary Employer
Howard L Sofen, MD a Medical Corporation
drsofen.com
HQ Phone
Get M.D. Howard's Phone Numberphone_androidMobile
Get M.D. Howard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1982 - 2025
CA State Medical License
American Board of Dermatology
Dermatology
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Dermatology
1982 - 1985
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Internship • Internal Medicine
1981 - 1982
Drexel University College Of Medicine
drexel.edu
Medical School
Until 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 122 | 213 |
| 2 | 17000Destruction of skin growth | 82 | 116 |
| 3 | 17004Destruction of 15 or more skin growths | 75 | 155 |
| 4 | 17003Destruction of 2-14 skin growths | 70 | 543 |
| 5 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 57 | 82 |
Authors: Mark Lebwohl, Abby Van Voorhees, Stephen Tyring, Yao Wang, Linda Stein Gold, Ashley Cauthen, Bruce Strober
Journal: J Am Acad Dermatol
Publication Date: 2020-02-04
A reliability study using Network-Oriented Research Assistant to evaluate the use of digital photographs in the assessment of atopic dermatitis.
Authors: Consuelo David, Mayha Patel, Jonathan Cotliar, Reyhaneh Hamidi, Noah Craft, Belinda Tan
Publication Date: 2018-08-28
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: Placebo, DRUG: BIIB059 (litifilimab)
Lead Sponsor: Incyte Corporation
Intervention / Treatment: DRUG: Vehicle Cream, DRUG: Ruxolitinib Cream
Lead Sponsor: Asana BioSciences
Intervention / Treatment: DRUG: ASN002